Cancer stem cell differentiation: TGF beta 1 and versican may trigger molecules for the organization of tumor spheroids


Creative Commons License

ÖKTEM G. , Sercan O., GUVEN U., USLU R. , UYSAL A. , Goksel G., et al.

ONCOLOGY REPORTS, cilt.32, ss.641-649, 2014 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 32 Konu: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3892/or.2014.3252
  • Dergi Adı: ONCOLOGY REPORTS
  • Sayfa Sayısı: ss.641-649

Özet

Cancer stem cells (CSCs) have the ability to self-renew similar to normal stem cells. This process is linked with metastasis and resistance to chemotherapy and radiotherapy. In the present study, we constructed an in vitro differentiation model for CSCs. CSCs isolated and proliferated for one passage were maintained as monolayers or spheroid-forming cells with serum included media for differentiation process. Differentiation of adhesion molecules and cellular ultrastructural properties were investigated and compared in both monolayer and spheroid cultures. CD133(+)/CD44(+) cancer-initiating cells were isolated from DU-145 human prostate cancer cell line monolayer cultures and propagated as tumor spheroids and compared with the remaining heterogeneous cancer cell bulk population. Microarray-based gene expression analysis was applied to determine genes with differential expression and protein expression levels of candidates were analyzed by immunohistochemistry. Electron microscopy showed detailed analysis of morphology. TGF beta 1 was found to be significantly upregulated in monolayer CSCs. High expression levels of VCAN, COL7A1, 1TG beta 3, MMP16, RPL13A, COL4A2 and TIMP1 and low expression levels of THBS1, MMP1 and MMP14 were detected when CSCs were maintained as serum-grown prostate CSC spheroids. Immunohistochemistry supported increased immunoreactivity of TG beta 1 in monolayer cultures and VCAN in spheroids. CSCs were found to possess multipotential differentiation capabilities through upregulation and/or downregulation of their markers. TGF beta 1 is a triggering molecule, it stimulates versican, Co17A1, ITG beta 3 and, most importantly, the upregulation of versican was only detected in CSCs. Our data support a model where CSCs must be engaged by one or more signaling cascades to differentiate and initiate tumor formation. This mechanism occurs with intracellular and extracellular signals and it is possible that CSCc themselves may be a source for extracellular signaling. These molecules functioning in tumor progression and differentiation may help develop targeted therapy.